Jingxue Shi
- Molecular Biology
- Oncology
- Small Animals top 10%
- Clinical Biochemistry top 10%
- Immunology
- Topics
- Cancer-related Molecular Pathways (5 papers)interferon and immune responses (3 papers)Ubiquitin and proteasome pathways (3 papers)
- Partner nations
- United StatesChinaIreland
In The Last Decade
Jingxue Shi
15 papers receiving 408 citations
Peers
Comparison fields: 5 of 84
- Molecular Biology 268
- Oncology 59
- Small Animals 45
- Clinical Biochemistry 43
- Immunology 42
Countries citing papers authored by Jingxue Shi
This map shows the geographic impact of Jingxue Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingxue Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingxue Shi more than expected).
Fields of papers citing papers by Jingxue Shi
This network shows the impact of papers produced by Jingxue Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingxue Shi. The network helps show where Jingxue Shi may publish in the future.
Co-authorship network of co-authors of Jingxue Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Jingxue Shi. A scholar is included among the top collaborators of Jingxue Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingxue Shi. Jingxue Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 28 | |
| 3 | 15 | |
| 4 | 27 | |
| 5 | 16 | |
| 6 | 24 | |
| 7 | 101 | |
| 8 | 5 | |
| 9 | 32 | |
| 10 | 38 | |
| 11 | 69 | |
| 12 | 6 | |
| 13 | Characterization of Human Homeodomain-interacting Protein Kinase 4 (HIPK4) as a Unique Member of the HIPK Family. | 15 |
| 14 | 8 | |
| 15 | 16 |
About Jingxue Shi
Jingxue Shi is a scholar working on Small Animals, Oncology and Molecular Biology, having authored 15 papers that have together received 412 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), interferon and immune responses (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Clinical Biochemistry (43 citations), Small Animals (45 citations) and Molecular Biology (268 citations). Jingxue Shi has collaborated with scholars based in United States, China and Ireland. Frequent co-authors include M. Saeed Sheikh, Ying Huang, Qin He, Jie An, Ki Lui, Yuxin Liu, Xiuquan Luo, JoAnne Montalbano, Ying Huang and James A. Hewett. Their work appears in journals such as Journal of Biological Chemistry, Analytical Chemistry and Journal of Cell Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.